Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Harmonic Inc
HLIT
$1.3B
| $752K | ﹤0.01% |
51,530
-1,440
| -3% | -$19.9K |
|
527
COPT Defense Properties
CDP
$4.24B
| $746K | ﹤0.01% |
+31,465
| New | +$809K |
|
528
Vir Biotechnology
VIR
$1.54B
| $746K | ﹤0.01% |
32,049
+7,505
| +31% | +$192K |
|
|
NEE.PRR
529
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| $742K | ﹤0.01% |
16,000
| – | – |
|
530
Buckle
BKE
$2.34B
| $741K | ﹤0.01% |
+20,755
| New | +$851K |
|
531
Newmont
NEM
$110B
| $728K | ﹤0.01% |
14,846
-77,439
| -84% | -$3.75M |
|
|
AEL
532
DELISTED
American Equity Investment Life Holding Company
AEL
| $718K | ﹤0.01% |
19,682
-1,871
| -9% | -$79.5K |
|
533
SFL Corp
SFL
$1.58B
| $713K | ﹤0.01% |
75,063
-7,643
| -9% | -$75.5K |
|
534
Fluor
FLR
$7.04B
| $711K | ﹤0.01% |
+22,993
| New | +$791K |
|
|
ZUO
535
DELISTED
Zuora, Inc.
ZUO
| $706K | ﹤0.01% |
71,471
-88,660
| -55% | -$743K |
|
536
Editas Medicine
EDIT
$422M
| $695K | ﹤0.01% |
95,854
+2,977
| +3% | +$26.5K |
|
537
Matador Resources
MTDR
$5.84B
| $692K | ﹤0.01% |
14,527
-461
| -3% | -$25.9K |
|
538
SunCoke Energy
SXC
$816M
| $688K | ﹤0.01% |
+76,592
| New | +$700K |
|
539
Liberty Energy
LBRT
$3.17B
| $683K | ﹤0.01% |
+53,287
| New | +$788K |
|
540
FirstService
FSV
$6.35B
| $677K | ﹤0.01% |
4,808
+550
| +13% | +$75.8K |
|
|
BRSL
541
Brightstar Lottery PLC
BRSL
$2.08B
| $676K | ﹤0.01% |
+25,216
| New | +$646K |
|
542
8x8 Inc
EGHT
$328M
| $674K | ﹤0.01% |
161,722
-58,840
| -27% | -$294K |
|
543
Lantheus
LNTH
$6.61B
| $670K | ﹤0.01% |
+8,111
| New | +$523K |
|
544
BridgeBio Pharma
BBIO
$16.1B
| $667K | ﹤0.01% |
40,224
-58,730
| -59% | -$685K |
|
545
Regenxbio
RGNX
$672M
| $666K | ﹤0.01% |
35,228
-6,127
| -15% | -$136K |
|
|
ITCI
546
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $666K | ﹤0.01% |
12,293
-3,761
| -23% | -$182K |
|
|
CSGS
547
DELISTED
CSG Systems International
CSGS
| $656K | ﹤0.01% |
12,223
-512
| -4% | -$29.1K |
|
548
Halozyme
HALO
$9.91B
| $654K | ﹤0.01% |
+17,131
| New | +$804K |
|
|
ARCH
549
DELISTED
Arch Resources, Inc.
ARCH
| $638K | ﹤0.01% |
4,854
| – | – |
|
550
Kforce
KFRC
$1.05B
| $628K | ﹤0.01% |
9,938
-6,623
| -40% | -$393K |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.